Dr. James Kiley: June 8, 2017

Play

COPD NATIONAL ACTION PLAN AIMS TO REDUCE THE BURDEN OF THE THIRD LEADING CAUSE OF DEATH 

First-Ever National Framework Designed to Address Key Issues Associated with COPD 

Dr. James Kiley

Director of the Division of Lung Diseases at the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)

The National Heart, Lung, and Blood Institute (NHLBI), along with federal and nonfederal partners, recently released the first-ever COPD National Action Plan, a detailed, patient-centered roadmap for addressing one of the most urgent health concerns facing Americans. The plan was released at the American Thoracic Society International Conference in Washington, DC. NHLBI is part of the National Institutes of Health.

The third leading cause of death in the United States, chronic obstructive pulmonary disease, or COPD, affects 16 million American diagnosed with the disease and millions more who likely do not know they have it. The disease, which costs Americans more than $32 billion a year, can stifle a person’s ability to breathe, lead to long-term disability, and dramatically affect quality of life. This forward-looking plan—developed in conjunction with the COPD community nationwide and at the request of Congress—offers a unified, coordinated approach to ending the COPD scourge by identifying the specific work doctors, educators, researchers, federal agencies, patients, advocates, and the biomedical industry can do to make a difference.

With early diagnosis and treatment, people with COPD can improve their quality of life and begin to breathe a little easier. On June 8, Dr. James Kiley, Director of the Division of Lung Diseases at the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH) will be available for interviews. He’ll discuss the COPD National Action Plan, how patients and health providers can work better together, and how your listeners can help raise awareness about COPD in their communities.

For more information please visit: http://www.COPD.nih.gov/

  

More About Dr. James Kiley:

James P. Kiley joined the National Heart, Lung, and Blood Institute (NHLBI), in the National Institutes of Health (NIH), as a health scientist administrator in the Institute’s Division of Lung Diseases (DLD). He subsequently served as chief of the Division’s Airways Diseases Branch, Director of the NIH National Center on Sleep Disorders Research, and currently serves as Director of the Division of Lung Diseases. Dr. Kiley’s primary research interests include obstructive lung diseases and sleep.

Dr. Kiley received his M.S. and Ph.D. degrees from Kansas State University, Manhattan, Kansas, and a B.S. degree from St. Anselm’s College, Manchester, New Hampshire. He was a postdoctoral fellow and a faculty member at the University of North Carolina, Chapel Hill, NC.

Dr. Kiley is the author or coauthor of more than 100 scientific publications and abstracts. He has served as a reviewer for multiple scientific journals.

Speak Your Mind

*